Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology

Version 1 : Received: 5 April 2023 / Approved: 6 April 2023 / Online: 6 April 2023 (08:59:14 CEST)

How to cite: Alhasan, K.A.; Yepes-Nuñez, J.J.; Askandarani, S.; Amer, Y.S.; Al-Jelaify, M.; Almatham, K.I.; Al-Ghonaim, M.; Al Dalbhi, S.; Kari, J.A.; Mitwalli, A.; Memish, Z.; Valson, J.S.; Alvira, X.; Bilimoria, K.; Chawla, R.; Feit, S.; Bickett, S.; Brunnhuber, K. Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology. Preprints 2023, 2023040080. https://doi.org/10.20944/preprints202304.0080.v1 Alhasan, K.A.; Yepes-Nuñez, J.J.; Askandarani, S.; Amer, Y.S.; Al-Jelaify, M.; Almatham, K.I.; Al-Ghonaim, M.; Al Dalbhi, S.; Kari, J.A.; Mitwalli, A.; Memish, Z.; Valson, J.S.; Alvira, X.; Bilimoria, K.; Chawla, R.; Feit, S.; Bickett, S.; Brunnhuber, K. Adapting Clinical Practice Guidelines for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children in the Saudi Arabian context using the GRADE-ADOLOPMENT methodology. Preprints 2023, 2023040080. https://doi.org/10.20944/preprints202304.0080.v1

Abstract

Background: This practice guideline was developed by the Chronic Kidney Disease (CKD) Task Force, which was composed of clinical and methodological experts. The Saudi Arabian Ministry of Health and its Health Holding Company commissioned this guideline project to support the realization of the Vision 2030's healthcare transformation pillar. Methods: The guideline synthesis was guided by the GRADE-ADOLOPMENT methodology. Results: The final adoloped guideline addressed 12 clinical questions on blood pressure management in patients with CKD through a set of recommendations and performance measures. The recommendations included antihypertensive agents in children, non-renin angiotensin system inhibition (Non-RASi) vs RASi in adults, intensive vs standard blood pressure targets, early vs late assessment for kidney replacement therapy (KRT), late vs early preparation strategy for KRT, CKD symptoms during assessment for KRT or conservative management, initiation of KRT in patients with deteriorating CKD, choice of KRT modality or conservative management in certain CKD patient groups, changing or discontinuing KRT modalities, review frequency for KRT or conservative management, and Information, education and support. Conclusions: These conditional recommendations were based on low to very low certainty of evidence that highlights the need for high-quality randomized trials comparing different antihypertensive agents in patients with CKD.

Keywords

chronic kidney disease; antihypertensive; practice guidelines; recommendations; performance measures; GRADE; adolopment; AGREE II; RIGHT-Ad@pt; evidence-based healthcare; Saudi Arabia

Subject

Medicine and Pharmacology, Urology and Nephrology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.